IL4R and cancer: In contrast, mice deficient in IL-4R in the granulocyte-monocyte progenitors exhibited poorer cancer growth than wild-type mice and had much smaller numbers of mo-mac in cancer, suggesting that IL-4 signaling is a prerequisite for the development of MDCSs.